These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30994537)

  • 1. Diagnostic Significance of HRAS Mutations in Epithelial-Myoepithelial Carcinomas Exhibiting a Broad Histopathologic Spectrum.
    Urano M; Nakaguro M; Yamamoto Y; Hirai H; Tanigawa M; Saigusa N; Shimizu A; Tsukahara K; Tada Y; Sakurai K; Isomura M; Okumura Y; Yamaguchi H; Matsubayashi J; Nagao T
    Am J Surg Pathol; 2019 Jul; 43(7):984-994. PubMed ID: 30994537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diagnostic Utility of RAS Q61R Mutation-specific Immunohistochemistry in Epithelial-Myoepithelial Carcinoma.
    Nakaguro M; Tanigawa M; Hirai H; Yamamoto Y; Urano M; Takahashi RH; Sukeda A; Okumura Y; Honda S; Tasaki K; Shimizu A; Tsukahara K; Tada Y; Matsubayashi J; Faquin WC; Sadow PM; Nagao T
    Am J Surg Pathol; 2021 Jul; 45(7):885-894. PubMed ID: 33481388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
    Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
    Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-Myoepithelial Carcinoma.
    Nakaguro M; Nagao T
    Surg Pathol Clin; 2021 Mar; 14(1):97-109. PubMed ID: 33526226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2018 Mar; 42(3):319-325. PubMed ID: 29135517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.
    El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S
    Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component.
    Skálová A; Weinreb I; Hyrcza M; Simpson RH; Laco J; Agaimy A; Vazmitel M; Majewska H; Vanecek T; Talarčik P; Manajlovic S; Losito SN; Šteiner P; Klimkova A; Michal M
    Am J Surg Pathol; 2015 Mar; 39(3):338-48. PubMed ID: 25581728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights into Tumor Heterogeneity: A Case of Solid-Oncocytic Epithelial-Myoepithelial Carcinoma of the Parotid Gland Harboring a HRAS and Heterogeneous Terminating ARID1A Mutation.
    Rupp NJ; Brada M; Skálová A; Bode B; Broglie MA; Morand GB; Rechsteiner M; Freiberger SN
    Head Neck Pathol; 2020 Jun; 14(2):554-558. PubMed ID: 31309433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sebaceous epithelial-myoepithelial carcinoma of the salivary gland: clinicopathologic and immunohistochemical analysis of 6 cases of a new histologic variant.
    Shinozaki A; Nagao T; Endo H; Kato N; Hirokawa M; Mizobuchi K; Komatsu M; Igarashi T; Yokoyama M; Masuda S; Sano K; Izumi M; Fukayama M; Mukai K
    Am J Surg Pathol; 2008 Jun; 32(6):913-23. PubMed ID: 18425042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRAS mutations in epithelial-myoepithelial carcinoma.
    Chiosea SI; Miller M; Seethala RR
    Head Neck Pathol; 2014 Jun; 8(2):146-50. PubMed ID: 24277618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerosing Polycystic Adenoma of Salivary Glands: A Novel Neoplasm Characterized by PI3K-AKT Pathway Alterations-New Insights Into a Challenging Entity.
    Skálová A; Baněčková M; Laco J; Di Palma S; Agaimy A; Ptáková N; Costes-Martineau V; Petersson BF; van den Hout MFCM; de Rezende G; Klubíčková N; Koblížek M; Koshyk O; Vaneček T; Leivo I
    Am J Surg Pathol; 2022 Feb; 46(2):268-280. PubMed ID: 34510113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
    Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
    Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary epithelial-myoepithelial carcinoma without AKT1, HRAS or PIK3CA mutations: a case report.
    Yanagawa N; Sato A; Nishiya M; Suzuki M; Sugimoto R; Osakabe M; Uesugi N; Saito H; Sugai T
    Diagn Pathol; 2020 Aug; 15(1):105. PubMed ID: 32859224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary Sialadenoma Papilliferum Consists of Two Morphologically, Immunophenotypically, and Genetically Distinct Subtypes.
    Hsieh MS; Bishop JA; Wang YP; Poh CF; Cheng YL; Lee YH; Jin YT; Chang JYF
    Head Neck Pathol; 2020 Jun; 14(2):489-496. PubMed ID: 31473937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
    Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
    Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial myoepithelial carcinoma of the parotid gland with malignant ductal and myoepithelial components arising in a pleomorphic adenoma: a case report with cytologic, histologic and immunohistochemical correlation.
    Daneshbod Y; Negahban S; Khademi B; Daneshbod K
    Acta Cytol; 2007; 51(5):807-13. PubMed ID: 17910353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo assessment of targeted therapies in a rare metastatic epithelial-myoepithelial carcinoma.
    Mäkelä R; Arjonen A; Suryo Rahmanto A; Härmä V; Lehtiö J; Kuopio T; Helleday T; Sangfelt O; Kononen J; Rantala JK
    Neoplasia; 2020 Sep; 22(9):390-398. PubMed ID: 32645560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary epithelial-myoepithelial carcinoma: clinical, morphological and molecular features.
    De Cecio R; Cantile M; Fulciniti F; Botti G; Foschini MP; Losito NS
    Pathologica; 2017 Mar; 109(1):1-8. PubMed ID: 28635988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialadenoma Papilliferum of the Bronchus: An Unrecognized Bronchial Counterpart of the Salivary Gland Tumor With Frequent BRAF V600E Mutations.
    Nakaguro M; Mino-Kenudson M; Urano M; Ogawa I; Honda Y; Hirai H; Tanigawa M; Sukeda A; Kajiwara N; Ohira T; Ikeda N; Mikami Y; Tada Y; Ikeda JI; Matsubayashi J; Faquin WC; Sadow PM; Nagao T
    Am J Surg Pathol; 2021 May; 45(5):662-671. PubMed ID: 33443864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
    Hsieh MS; Lee YH; Jin YT; Kuo YJ
    Virchows Arch; 2020 Oct; 477(4):581-592. PubMed ID: 32383006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.